Record #3656

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer

Citation lifecycle

How this paper is being cited

Pre-retraction
139
Same day
0
Post-retraction
99
% post-retraction
41.8%
~39.7 citations/yr before retraction · ~7.2 citations/yr after
citing papers

Who is still citing this work

Loading…